Viatris Aktie

13,70USD 0,19USD 1,41%
Viatris für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2QAME / ISIN: US92556V1061

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 37 000 37 000 38 000 32 000 30 000
Umsatz pro Mitarbeiter in Mio. EUR 0,48 0,44 0,40 0,46 0,48

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 10 903 10 635 12 229 8 994 9 221
Summe Anlagevermögen 43 940 39 387 35 457 32 507 27 972
Summe Aktiva 54 843 50 022 47 686 41 501 37 193

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 34 350 28 950 27 218 22 865 22 482
Summe Eigenkapital 20 493 21 072 20 467 18 636 14 711
Summe Passiva 54 843 50 022 47 686 41 501 37 193

Adresse

Robert J. Coury Global Center, 15317 Canonsburg
Telefon +1 (724) 514-1800
Internet http://www.viatris.com

Management

Abhijit Barve
Chief Medical Officer
Andrew Enrietti
Chief Administrative & Transformation Officer
Anil Amin
Chief Business Development Officer
Arun Narayan
Head-Commercial Development
Burt Park
Secretary & Chief Governance Counsel
Corinne Le Goff
Chief Commercial Officer
David Bayles
Chief Compliance Officer
David S. Simmons
Independent Director
Elisha Wade Finney
Independent Director
Frank A. D'Amelio
Independent Director
Hemanth J. Varghese
Chief Strategy Officer
James Marshall Kilts
Independent Director
Jill Sawyer
Investor Relations Contact
JoEllen Lyons Dillon
Independent Director
Kristin DiBartolomeo
Chief of Staff
Lara Ramsburg
Chief People & Corporate Affairs Officer
Leo Groothuis
Independent Director
Mark W. Parrish
Vice Chairman
Matthew Joseph Maletta
Chief Legal Officer
Melina E. Higgins
Chairman
Michael E. Severino
Independent Director
Paul B. Campbell
Chief Accounting Officer & Controller
Philippe Martin
Chief Research & Development Officer
Ramkumar V. Rayapureddy
Chief Information Officer
Richard A. Mark
Independent Director
Robert J. Coury
Chairman-Emeritus
Rogério Vivaldi Coelho
Independent Director
Scott Andrew Smith
Chief Executive Officer & Director
Theodora Mistras
Chief Financial Officer
William Szablewski
Head-Investor Relations
Wyllie Don Cornwell
Independent Director